Roche gets USFDA approval of Xofluza to treat influenza in children
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Urged stakeholders to come up with similar digital platforms and create homegrown best practices where Indian methods and Indian solutions dominate the digital spaces
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint, in these patients
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
First and only PARP inhibitor to improve invasive disease-free survival in patients
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
The curriculum has been curated for General Physicians working in Clinikk
Subscribe To Our Newsletter & Stay Updated